Burning Rock Biotech (BNR) Equity Ratio (2019 - 2025)

Burning Rock Biotech (BNR) has reported Equity Ratio for 8 consecutive years, with 0.66 the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Ratio fell 2.0% year-over-year to 0.66; the TTM figure through Mar 2026 stood at 0.66 (down 2.0% YoY), while the FY2025 annual figure was 0.65, down 0.55% from the prior year.
• Equity Ratio came in at 0.66 for Q1 2026 at Burning Rock Biotech, roughly flat from 0.65 in the prior quarter.
• The five-year high for Equity Ratio was 0.78 in Q1 2022, with the low at 0.65 in Q4 2025.
• Average Equity Ratio over 5 years is 0.71, with a median of 0.73 recorded in 2023.
• Across the five-year window, Equity Ratio dropped 11.68% in 2022 and increased 3.26% in 2025, its largest moves.
• Year by year, Equity Ratio stood at 0.73 in 2022, then rose by 1.26% to 0.74 in 2023, then dropped by 11.2% to 0.66 in 2024, then dropped by 0.55% to 0.65 in 2025, then gained by 0.48% to 0.66 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.66, 0.65, and 0.68 for Q1 2026, Q4 2025, and Q3 2025 respectively.